These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

821 related items for PubMed ID: 2971155

  • 21. Effect of oversulfated dermatan sulfate derivatives on platelet aggregation.
    Maaroufi RM, Giordano P, Triadou P, Tapon-Bretaudière J, Dautzenberg MD, Fischer AM.
    Thromb Res; 2007; 120(4):615-21. PubMed ID: 17222891
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Inhibition of thrombin by antithrombin III and heparin cofactor II in vivo.
    Liu L, Dewar L, Song Y, Kulczycky M, Blajchman MA, Fenton JW, Andrew M, Delorme M, Ginsberg J, Preissner KT.
    Thromb Haemost; 1995 Mar; 73(3):405-12. PubMed ID: 7545318
    [Abstract] [Full Text] [Related]

  • 27. Modulation of heparin cofactor II function by S protein (vitronectin) and formation of a ternary S protein-thrombin-heparin cofactor II complex.
    Preissner KT, Sié P.
    Thromb Haemost; 1988 Dec 22; 60(3):399-406. PubMed ID: 2976993
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Further studies on the mechanisms for the antithrombotic effects of sulfated polysaccharides in rabbits.
    Ofosu FA, Fernandez F, Anvari N, Caranobe C, Dol F, Cadroy Y, Petitou M, Mardiguian J, Sié P, Boneu B.
    Thromb Haemost; 1988 Oct 31; 60(2):188-92. PubMed ID: 2905842
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. An algal sulfated galactan has an unusual dual effect on venous thrombosis due to activation of factor XII and inhibition of the coagulation proteases.
    Melo FR, Mourão PA.
    Thromb Haemost; 2008 Mar 31; 99(3):531-8. PubMed ID: 18327401
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. The importance of thrombin inhibition for the expression of the anticoagulant activities of heparin, dermatan sulphate, low molecular weight heparin and pentosan polysulphate.
    Ofosu FA, Blajchman MA, Modi GJ, Smith LM, Buchanan MR, Hirsh J.
    Br J Haematol; 1985 Aug 31; 60(4):695-704. PubMed ID: 2411283
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Unfractionated heparin inhibits thrombin-catalysed amplification reactions of coagulation more efficiently than those catalysed by factor Xa.
    Ofosu FA, Hirsh J, Esmon CT, Modi GJ, Smith LM, Anvari N, Buchanan MR, Fenton JW, Blajchman MA.
    Biochem J; 1989 Jan 01; 257(1):143-50. PubMed ID: 2920007
    [Abstract] [Full Text] [Related]

  • 39. Heparin cofactor II is degraded by heparan sulfate and dextran sulfate.
    Saito A.
    Biochem Biophys Res Commun; 2015 Feb 20; 457(4):585-8. PubMed ID: 25600805
    [Abstract] [Full Text] [Related]

  • 40. Source-induced fragmentation of heparin, heparan, and galactosaminoglycans and application.
    Hu P, Fang L, Chess EK.
    Anal Chem; 2009 Mar 15; 81(6):2332-43. PubMed ID: 19228018
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 42.